Nutraceutical health claims in Indian advertising lack the evidence to support them, according to a review by the Advertising Standards Council of India. The regulator examined 61 advertisements between July and September 2026, and found that all 60 cases it completed were in violation of its code. The findings were published in a report titled “A Pill for Thought: Review of Health and Wellness Claims in Nutraceutical Advertising”, released on 28 October. The report is the fullest check yet of nutraceutical health claims in Indian advertising.
The claims examined included “Lose 6 kilograms in 60 days”, “your skin, but seven years younger”, “reverse asthma or polycystic ovarian disease” and “300% stronger skin defence against ultraviolet damage”. Weight management was the most common theme, followed by skincare and anti-ageing claims, respiratory health, and claims that edged into the treatment of specific diseases.
Of the 60 completed cases, 29 advertisers did not contest the objections raised against them. The other 31 contested the objections but failed to provide adequate substantiation for their advertising claims. The review found no clinical evidence or independent test reports showing the finished products could deliver the advertised benefits.
What the nutraceutical health claims promised
Most of the advertisements carrying nutraceutical health claims featured promises tied to specific deadlines, visuals, and claims that the products were safer alternatives to established therapies. The report said those techniques created unrealistic expectations among viewers, and that the promises went beyond what the evidence could support.
Manisha Kapoor, chief executive officer and secretary general of ASCI, said consumers turn to nutraceuticals in good faith, often seeking solutions for concerns that affect their health and wellbeing. She said that as the category grows, it is important that the strength of advertising claims matches the evidence available, so consumers can make informed decisions and trust is not compromised by promises that go beyond proof.
The review was a suo motu investigation into nutraceutical health claims, which means ASCI started it on its own initiative rather than in response to a complaint. It was carried out amid recurring concern about the substantiation of health and wellness claims made for nutraceutical products, and it was a targeted investigation of advertisements promoting health claims rather than a representative survey of the entire industry.
Regulators act on nutraceutical health claims
The Food Safety and Standards Authority of India, known as FSSAI, has stepped up scrutiny of nutraceutical health claims in the fast growing supplements industry, above all for products sold online. The regulator is reviewing approvals granted as far back as three to five years ago, to check whether companies are making claims they were not cleared to use, and it plans to issue notices and suspend licences where it finds violations.
On 16 November, FSSAI said it had taken regulatory action against six nutraceutical manufacturers, including licence suspension, over serious food safety violations. The six companies were Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies. Inspectors found products with ingredients above the prescribed recommended dietary allowance limits, unauthorised claims, and a vitamin E softgel capsule that contained wheat germ oil instead of vitamin E.
FSSAI has also said it plans to require online listings to display manufacturing and expiry dates and batch numbers of food products, and to hold platforms accountable for nutraceutical health claims made by manufacturers. The regulator has increased scrutiny of food manufacturers, hotels and restaurants for advertising, product claims, infant product marketing, labelling and food storage, and it conducted about 700,000 inspections between April and September, almost double the number from a year earlier.
States tighten nutraceutical health claims too
Maharashtra’s Food and Drug Administration is preparing to widen scrutiny of nutraceutical health claims, from the ingredients inside a supplement to the contents on its packaging. Commissioner Tukaram Mundhe described the department’s findings as disturbing, and said products claim to contain an ingredient that is not actually there. The department plans to cover contents, labelling, consumption and selling.
Uttar Pradesh has gone further. Its Food Safety and Drug Administration has prohibited misleading disease specific names and unsubstantiated medical claims on nutraceuticals, and has made the declaration “Not for Medicinal Use” mandatory on every pack. Names such as “Diabetes Care”, “Arthritis Care”, “Kidney Care”, “Liver Detox”, “Cardio Care”, “Thyroid Care”, “Blood Sugar Control” and “Disease Management” are now prohibited examples in the state.
The order in Uttar Pradesh covers health supplements, nutraceuticals, foods for special dietary uses, foods for special medical purposes, probiotics and prebiotics. It follows a review that detected violations involving unauthorised ingredients, prescribed dosage limits, recommended dietary allowances, misleading product names, incorrect labelling and health related claims without adequate scientific evidence. Nutraceutical health claims cannot promise to diagnose, cure, prevent or treat any disease, and the regulators are now acting on that rule.

